A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Independent Coverage of the 2007 San Antonio Breast Cancer Symposium

Expert Interview: Highlights and Clinical Implications with Lee Schwartzberg, MD, Director, The West Clinic -CME

Bone Loss and Bone Metastases in Breast Cancer: A Report from the 2007 SABCS -CME

Predicting Response and Individualizing Therapy in the Adjuvant Setting: Are We Making Progress?

Updates in the Management of Metastatic Breast Cancer -CME

  • Treatment Related Side Effects for Metastatic Breast Cancer: Are We Making Progress?
  • Advances in the Management of HER2 Positive Metastatic Breast Cancer 
  • The Evolving Role of Targeted Therapy in Metastatic Breast Cancer
  • Emerging Strategies for the Management of Triple-Negative Metastatic Breast Cancer

About the Authors

Lee Schwartzberg, MD

Dr. Lee Schwartzberg is a senior partner at The West Clinic in Memphis, Tennessee. He did a residency in Internal Medicine at Cornell University and fellowship training in Hematology and Oncology at Memorial Sloan-Kettering Cancer Center where he was chief resident in Medicine. He is a Clinical Professor of Medicine at The University of Tennessee College of Medicine. He serves as the Medical Director of the Baptist Cancer Institute-Stem Cell Transplant Program and the Cancer Assessment Risk Evaluation and Surveillance (CARES) Genetics Program. Dr. Schwartzberg has authored over fifty research papers and serves as the Director of Research for The West Clinic.

Georgiana K. Ellis, MD

Dr. Georgiana K. Ellis is an Associate Professor in the Medical Oncology Division at the Univerisity of Washington School of Medicine and an Oncology Specialist at the Seattle Cancer Care Alliance. Dr. Ellis received her medical degree from the University of Washington, Seattle, Washington and completed her Internal Medicine Residency and was a Post-Doctoral Fellow in Oncology at the University of Washington, Seattle, Washington. Her clinical interests are in breast cancer-multidisciplinary care, dose intrinsity in cancer chemotherapy, and maximizing breast cancer cures.

Lori Goldstein, MD

Dr. Lori J. Goldstein is the Director, Breast Evaluation Center and
Leader, Breast Cancer Research Program at the Fox Chase Cancer Center in Philadelphia, Pennsylvania. In an effort to contribute to the reduction of both the incidences of breast cancer and the morbidity and mortality due to this disease, her research focuses on a multidisciplinary program encompassing basic, clinical, and prevention and control research.

Disclaimer

Notwithstanding any language to the contrary, nothing contained herein constitutes, nor is intended to constitute, an offer, inducement, promise, or contract of any kind. The data contained herein are for informational purposes only and are not represented to be error free. Any links to non-Creative Educational Concepts, Inc. (CEC) information are provided as a courtesy. They are not intended to constitute, nor do they constitute, an endorsement of the linked materials by CEC .

Supporters

The CME portion of these activities is supported by an educational donation from Amgen and educational grants from Novartis, Bristol-Myers Squibb Company, Wyeth Pharmaceuticals and Genomic Health.

Related Articles in this Activity:

Expert Interview: Highlights and Clinical Implications with Lee Schwartzberg, MD, Director, The West Clinic 

Coming Soon

 




© 1998-2007 CancerConsultants.com  All Rights Reserved.